Related Links Educational Materials About Clinical Trials Clinical Trials Questions to Ask Your Doctor Drug Information from MedlinePlus

Alternate Title
Basic Trial Information
Trial Description
     Purpose
     Eligibility
     Treatment/Intervention
Trial Contact Information
Registry Information

Alternate Title

Study of Attitudes Toward the Risk of Infertility Related to Adjuvant Therapy in Women With Early Breast Cancer

Basic Trial Information

Phase	Type	Status	Age	Sponsor	Protocol IDs
No phase specified	Educational/Counseling/Training	Active	35 and under at diagnosis	Other	EORTC-10002 BIG-3-98, NCT00062400

Trial Description

Purpose:

Adjuvant therapy given after surgery for early breast cancer may cause infertility. Assessing young women's attitudes and feelings about the risk of infertility may help improve the ability to plan effective treatment.

This clinical trial is studying young women's attitudes and feelings about the risk of infertility related to adjuvant therapy for stage I or stage II breast cancer.

Eligibility:

Eligibility criteria include the following:

• Younger than 36 years old at diagnosis
• No relapsed disease
• Regular menstrual periods for the past 3 months
• For more information about the eligibility criteria for this trial, refer to the Health Professional version.

Final eligibility for a clinical trial is determined by the health professionals conducting the trial.

Treatment/Intervention:

Patients will complete a questionnaire.

Important:

For more details about this trial, refer to the Health Professional version of the trial summary.

If you are interested in participating in a clinical trial, contact your doctor for a referral or call a trial contact person listed below. You may see the same contact person listed at more than one site, however, if you call the number listed you can ask to speak to the study coordinator or person involved with the specific trial you are interested in. If you have questions about cancer or clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). General information about clinical trials, including risks, benefits, and costs, can be found on NCI's Web site.

Trial Contact Information

Trial Lead Organizations

European Organization for Research and Treatment of Cancer

Angelo Di Leo, MD, Study coordinator		Ph: 39-0574-43-4766 Email: adileo@usl4.toscana.it

Belgium
	Brussels
	Centre Hospitalier Etterbeek Ixelles
		Contact Person	Ph:  32-641-4111
	Institut Jules Bordet
		Contact Person	Ph:  32-2-541-3181
	Liege
	CHU Liege - Domaine Universitaire du Sart Tilman
		Contact Person	Ph:  32-4-366-7111
	Wilrijk
	Algemeen Ziekenhuis Sint-Augustinus
		Contact Person	Ph:  32-3-443-37-37
Chile
	Santiago
	Clinica Alemana
		Contact Person
	Hospital Militar
		Contact Person
	Instituto de Radiomedicina
		Contact Person	Ph:  56-2-754-1700
Croatia
	Zagreb
	University Hospital Rebro
		Contact Person	Ph:  385-1-238-8644
Germany
	Frankfurt
	Klinikum der J.W. Goethe Universitaet
		Contact Person	Ph:  49-69-6301-5744
	Heidelberg
	Universitatsklinikum Heidelberg
		Contact Person	Ph:  49-6221-56-7029
Italy
	Aviano
	Centro di Riferimento Oncologico - Aviano
		Contact Person	Ph:  39-0434-659-111
	Cremona
	Azienda Istituti Ospitalieri
		Contact Person	Ph:  372-405111
	Lecco
	Ospedale Alessandro Manzoni
		Contact Person
	Milan
	European Institute of Oncology
		Contact Person	Ph:  39-02-5748-9861
Lebanon
	Beirut
	American University of Beirut Medical Center
		Contact Person	Ph:  961-1-350-000
Netherlands
	Amsterdam
	Academisch Medisch Centrum at University of Amsterdam
		Contact Person	Ph:  31-20-566-9111
	Arnhem
	Arnhems Radiotherapeutisch Instituut
		Contact Person	Ph:  31-26-371-2412
Peru
	Lima
	Instituto Nacional de Enfermedades Neoplasicas
		Contact Person	Ph:  51-1-612-9700
Poland
	Gdansk
	Medical University of Gdansk
		Contact Person	Ph:  48-58-349-2000
Portugal
	Lisboa
	Instituto Portugues de Oncologia de Francisco Gentil - Centro Regional de Oncologia de Lisboa, SA
		Contact Person	Ph:  351-21-722-9800
Republic of South Africa
	Cape Town
	Groote Schuur Hospital
		Contact Person	Ph:  27-21-404-4265
Serbia
	Belgrade
	Institute of Oncology and Radiology of Serbia
		Contact Person	Ph:  381-361-4660
Switzerland
	Bern
	Inselspital Bern
		Contact Person	Ph:  41-31-632-2243
	Mendrisio
	Ospedale Beata Vergine
		Contact Person	Ph:  41-91-646-0101
	St. Gallen
	Kantonsspital - St. Gallen
		Contact Person	Ph:  41-71-494-1062
Turkey
	Istanbul
	Marmara University Hospital
		Contact Person	Ph:  90-327-5050
United Kingdom
Scotland
	Glasgow
	Western Infirmary
		Contact Person	Ph:  44-141-211-2000

Registry Information
Official Title		A Survey of the Breast International Group (B.I.G.) to Assess the Attitude of Patients Aged Less Than 35 Years, with Early Breast Cancer, Toward the Risk of Loss of Fertility Related to Adjuvant Therapies
Trial Start Date		2003-05-05
Trial Completion Date		2008-03-31 (estimated)
Registered in ClinicalTrials.gov		NCT00062400
Date Submitted to PDQ		2003-05-07
Information Last Verified		2009-06-14

Back to Top